ES2043861T3 - Procedimiento de preparacion de derivados de la bencimidazol-2-ona. - Google Patents

Procedimiento de preparacion de derivados de la bencimidazol-2-ona.

Info

Publication number
ES2043861T3
ES2043861T3 ES88400312T ES88400312T ES2043861T3 ES 2043861 T3 ES2043861 T3 ES 2043861T3 ES 88400312 T ES88400312 T ES 88400312T ES 88400312 T ES88400312 T ES 88400312T ES 2043861 T3 ES2043861 T3 ES 2043861T3
Authority
ES
Spain
Prior art keywords
carbon atoms
group
bencimidazole
preparation procedure
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88400312T
Other languages
English (en)
Inventor
Constantin Agouridas
Patrick Fauveau
Gilles Hamon
Lucien Nedelec
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of ES2043861T3 publication Critical patent/ES2043861T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

LA INVENCION SE REFIERE A LOS DERIVADOS DE LA BECIMIDAZOL-2-ONA Y SUS SALES DE ACIDOS MINERALES U ORGANICOS, QUE RESPONDEN A LA FORMULA (I) DONDE R ES HIDROGENO, ALQUILO (1 A 5 CARBONOS), CICLOALQUILALQUILO (4 A 7 CARBONOS), ARALQUILO (7 A 12 CARBONOS), EVENTUALMENTE SUSTITUIDO CON ALQUILO (1 A 5 CARBONOS, ALCOXI (1 A 5 CARBONOS) O CON HALOGENO, O R ES ALQUENILO ( 3 A 5 CARBONOS, EL ENLACE MULTIPLE NO PUEDE ENCONTRARSE ENTRE LOS CARBONOS EN ALFA Y BETA DEL NITROGENO Y R1 ES HIDROGENO, HIDROXI, ALCOSI (1 A 5 CARBONOS), FENILALQUILOXI (7 A 9 CARBONOS) O FENOXI. LA INVENCION TIENE TAMBIEN POR OBJETO LA PREPARACION DE COMPUESTOS (I), SU APLICACION COMO MEDICAMENTOS, LAS COMPOSICIONES QUE LOS CONTIENEN Y LOS PRODUCTOS INTERMEDIOS.
ES88400312T 1987-02-13 1988-02-11 Procedimiento de preparacion de derivados de la bencimidazol-2-ona. Expired - Lifetime ES2043861T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8701836A FR2610929B1 (fr) 1987-02-13 1987-02-13 Derives de la benzimidazol-2-one, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant et intermediaires

Publications (1)

Publication Number Publication Date
ES2043861T3 true ES2043861T3 (es) 1994-01-01

Family

ID=9347894

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88400312T Expired - Lifetime ES2043861T3 (es) 1987-02-13 1988-02-11 Procedimiento de preparacion de derivados de la bencimidazol-2-ona.

Country Status (9)

Country Link
US (1) US4831043A (es)
EP (1) EP0282373B1 (es)
JP (1) JP2651917B2 (es)
AT (1) ATE81125T1 (es)
CA (1) CA1308721C (es)
DE (1) DE3874920T2 (es)
ES (1) ES2043861T3 (es)
FR (1) FR2610929B1 (es)
GR (1) GR3006136T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2688504B1 (fr) * 1992-03-13 1995-05-05 Synthelabo Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
WO1997016186A1 (en) * 1995-10-31 1997-05-09 Merck & Co., Inc. Muscarine agonists
AU2003244160A1 (en) * 2002-06-25 2004-01-06 Sumitomo Pharmaceuticals Co., Ltd. Novel benzoxazolinone derivative
CN109020923A (zh) * 2017-06-12 2018-12-18 上海百灵医药科技有限公司 一种氟班色林中间体的制备方法及其中间体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2458549A1 (fr) * 1979-06-12 1981-01-02 Roussel Uclaf Nouveaux derives de l'indole, leur procede de preparation et leur application comme medicaments
FR2510111A1 (fr) * 1981-07-24 1983-01-28 Roussel Uclaf Nouveaux derives du piperidin-3-yl indole, leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
FR2510112A1 (fr) * 1981-07-24 1983-01-28 Roussel Uclaf Nouveaux derives du 2-oxo-pyrid-3-yl ou piperidin-3-yl indole, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
US4458076A (en) * 1983-05-31 1984-07-03 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidinyl)-1,2-benzisothiazoles
EP0181793B1 (fr) * 1984-10-16 1988-07-27 Synthelabo Dérivés de pipéridine, leur préparation et leur application en thérapeutique
FR2578846B1 (fr) * 1985-03-12 1987-05-22 Roussel Uclaf Derives du 7-hydroxy indole, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant et intermediaires

Also Published As

Publication number Publication date
DE3874920T2 (de) 1993-05-13
DE3874920D1 (de) 1992-11-05
ATE81125T1 (de) 1992-10-15
EP0282373A1 (fr) 1988-09-14
JP2651917B2 (ja) 1997-09-10
US4831043A (en) 1989-05-16
GR3006136T3 (es) 1993-06-21
JPS63203680A (ja) 1988-08-23
FR2610929B1 (fr) 1989-06-23
CA1308721C (fr) 1992-10-13
EP0282373B1 (fr) 1992-09-30
FR2610929A1 (fr) 1988-08-19

Similar Documents

Publication Publication Date Title
ES2037098T3 (es) Procedimiento de preparacion de derivados de la decahidroquinoleina.
ES517699A0 (es) Procedimiento de preparacion de nuevas pirimido-quinoxalinas.
ES8304567A1 (es) "un procedimiento para preparar nuevos derivados de la n-dihidrotiazolil-3-quinolein-carboxamida".
DE3376421D1 (en) Analgesia-effecting 5-hydroxytryptophan derivatives
IE861633L (en) Carboxamide indole derivatives
ES2043861T3 (es) Procedimiento de preparacion de derivados de la bencimidazol-2-ona.
ES501000A0 (es) Procedimiento para preparar nuevos derivados de la indolo- benzoxazina
FR2510111B1 (es)
ES524990A0 (es) Procedimiento para preparar derivados de tieno-tiazol
EP0150139A3 (en) Indole-ethylphenol derivatives, their salts, process for their peparation, their uses as medicines and compositions containing them and intermediaries
GR3007599T3 (es)
DE3375300D1 (en) 9-oxalysergic-acid derivatives, their salts, process and intermediates for their preparation, their use as pharmaceutical preparations and compositions containing them
ES525712A0 (es) Un procedimiento para preparar nuevos derivados de la c-homo-9-oxaergolina
ES8207502A1 (es) Procedimiento para la preparacion de nuevos 1-ariloxi-3-al- cohilamino-2-propanoles
ES8204729A1 (es) Procedimiento para la preparacion de acidos de 2-(3'-tienil)propionicos 5'-sustituidos
GR880100111A (en) Preparation method of new derivatives of (dihydro-2,3 oxo-2 benzofuranil-3)-2 of acetic acid
DE3670493D1 (de) Pyrazolobenzoxazinderivate, ihre salze, verfahren und zwischenprodukte, verwendung als arzneimittel und diese enthaltende zubereitungen.
ES519530A0 (es) Procedimiento para la preparacion de tienobenzodiazepinonas sustituidas.
ES480765A1 (es) Procedimiento para la obtencion de 2-guanidinometil-indoli- nas.
JPS56154431A (en) Substituted 3-aryl-2-cycloalkene-1-one and its manufacture
ZA811149B (en) Cyclohepitindolol derivatives and their salts with the acids, their preparation, their use as medicaments and the compositions containing them
ES2038389T3 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas farmacologicamente activas.
ES2043631T3 (es) Procedimiento de preparacion de hidroxialquilxantinas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 282373

Country of ref document: ES